Journals / Türkderm-Deri Hastalıkları ve Frengi Arşivi / 2011 / Cilt: 45 - Sayı: 1

Generalized bullous fixed drug eruption associated with cetirizine and hydroxyzine demonstrated by patch test

Deri yama testiyle doğrulanmış setirizin ve hidroksizin ile ilişkili generalize büllöz fiks ilaç erüpsiyonu

Pages
49–52
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The test was positive for cetirizine, levocetirizine and hydroxyzine.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Fixed drug eruption (FDE) is characterized by solitary erythematous macules, edematous plaques and bullous lesions that occur at the same place with recurrent exposure to a drug.
📊
Key Findings & Data:Though more than 100 drugs have been implicated in leading to FDE, this side effect is more commonly caused by tetracyclines, sulfonamides, sulfone, penicillins, pyrazolones, barbiturates, phenolphthalein, pirazones, aspirin, oral contraceptives and nonsteroidal anti-inflammatory drugs.
💡
Conclusion & Impact:The test was positive for cetirizine, levocetirizine and hydroxyzine.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Fixed drug eruption (FDE) is characterized by solitary erythematous macules, edematous plaques and bullous lesions that occur at the same place with recurrent exposure to a drug. Though more than 100 drugs have been implicated in leading to FDE, this side effect is more commonly caused by tetracyclines, sulfonamides, sulfone, penicillins, pyrazolones, barbiturates, phenolphthalein, pirazones, aspirin, oral contraceptives and nonsteroidal anti-inflammatory drugs. FDE occurrence has been reported in association with cetrizine, hydroxyzine, loratadine and levocetirizine, which are widely used in the treatment of allergic diseases, such as allergic rhinitis, eczema, asthma, urticaria. Patch, intradermal skin, prick tests or oral challenge test can be performed to identify the agent responsible for FDE. A 43-year-old male patient attended our outpatient clinic with itchy and erythematous rashes with sporadic blisters, starting from dorsum of his feet and spreading to other parts of his body, following oral intake of cetirizine for allergic rhinitis. He described that his eruptions exacerbated with hydoxyzin. Patient’s history revealed that he had slightly suffered from the same cutaneous reactions one year ago, after oral administration of cetirizine. On physical examination, multiple, round, erythematoviolaceous, well-defined macules and plaques, with central blisters localized on the trunk, arms and legs were observed. Four months after the lesions regressed, patch test was performed to eight different antihistamines. The test was positive for cetirizine, levocetirizine and hydroxyzine.

Özet

Fiks ilaç erüpsiyonu, neden olan ilaçların tekrar eden alımları sonucunda aynı bölgelerde, genellikle soliter eritematöz parlak ya da koyu kırmızı makül, ödematöz plak ya da büllöz lezyonlar ile karakterizedir. Yüzden fazla ilaç suçlanmakla birlikte özellikle tetrasiklinler, sülfonamidler, sulfonlar, penisilinler, barbütiratlar, fenolfitolein, pirazolonlar, aspirin, oral kontraseptifler ve nonsteroid antiinflamatuvar ilaçlar sorumlu tutulmaktadır. Alerjik rinit, ekzema, astım, ürtiker gibi pek çok hastalığın tedavisinde yaygın şekilde kullanılan setirizin, hidroksizin, loratadin, levosetrizin gibi antihistaminiklere karşı da fiks ilaç erüpsiyon gelişimi bildirilmiştir. Sorumlu ajanın ortaya çıkarılmasında deri yama testi, intradermal testler, deri prick testi ya da oral uyarı testleri kullanılabilmektedir. Kırk üç yaşında erkek hasta alerjik rinit nedeniyle setirizin alımından yarım saat sonrasında ayak sırtlarından başlayarak tüm vücuda dağılan kaşıntılı yer yer su kabarcıkları içeren kızarıklıklar ile başvurdu. Döküntüleri başladıktan sonra hidroksizin kullanımıyla lezyonlarında artış olduğunu belirten hastanın öyküsünde 1 yıl önce de setirizin alımından sonra benzer yakınmalarının daha hafif bir şekilde olduğu öğrenildi. Deri bakısında vücutta yaygın eritemli, keskin sınırlı, yer yer büllöz makül ve plaklar gözlendi. Lezyonların gerilemesinden dört ay sonra sekiz farklı antihistaminikle yapılan deri yama testinde setirizin, levosetirizin ve hidroksizine karşı pozitiflik saptandı.

🔖

Cite This Article

KAÇAR, N., TAŞLI, L., ARSLAN, Ş., ERGİN, Ş. (2022). Generalized bullous fixed drug eruption associated with cetirizine and hydroxyzine demonstrated by patch test. Türkderm-Deri Hastalıkları ve Frengi Arşivi, Cilt: 45 - Sayı: 1, 49–52. https://ajindex.com/articles/622006

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (18)

  1. Pionetti CH, Kien MC, Alonso A. Fixed drug eruption due to loratadine Allergol Immunopathol 2003
  2. 3 2. Ada S, Yilmaz S: Ciprofloxacin-induced generalized bullous fixed drug eruption. Indian J Dermatol Venereol Leprol 2008
  3. Cravo M, Gonçalo M, Figueiredo A: Fixed drug eruption to cetirizine with positive lesional patch tests to the three piperazine derivatives Int J Dermatol 2007
  4. 2 4. Lew BL, Haw CR, Lee MH: Cutaneous drug eruption from cetirizine and hydroxyzine J Am Acad Dermatol 2004
  5. Stingeni L, Caraffini S, Agostinelli D, Ricci F, Lisi P: Maculopapular and urticarial eruption from cetirizine. Contact Dermatitis 1997
  6. Karamfilov T, Wilmer A, Hipler UC, Wollina U: Cetirizineinduced urticarial reaction. Br J Dermatol 1999
  7. Kranke B, Kern T: Multilocalized fixed drug eruption to the antihistamine cetirizine. J Allergy Clin Immunol 2000
  8. Calista D, Schianchi S, Morri M. Urticaria induced by cetirizine. Br J Dermatol 2001
  9. Assouère MN, Mazereeuw-Hautier J, Bonafé JL: Cutaneous drug eruption with two antihistaminic drugs of a same chemical family: cetirizine and hydroxyzine. Ann Dermatol Venereol 2002
  10. Inamadar AC, Palit A, Athanikar SB, Sampagavi VV, Deshmukh NS: Multiple fixed drug eruptions due to cetirizine. Br J Dermatol 2002
  11. Schroter S, Damveld B, Marsch WC: Urticarial intolerance reaction to cetirizine. Clin Exp Dermatol 2002
  12. Tella R, Gaig P, Bartra J, Garcia-Ortega P: Urticaria to cetirizine. J Invest Allergol Clin Immunol 2002
  13. Mahajan VK, Sharma NL, Sharma VC: Fixed drug eruption: a novel side-effect of levocetirizine Int J Dermatol 2005
  14. 8 14. Cusano F, Ferrara G, Crisman G, Sarracco G, Zalaudek I, Argenziano G: Clinicopathologic features of systemic contact dermatitis from ethylenediamine in cetirizine and levocetirizine. Dermatology 2006
  15. Chang YS, Kwon HS, Cho SH, Kim YY, Min KU: A case of urticaria induced by both hydroxyzine and cetirizine but not by levocetirizine. Allergy 2007
  16. Afonso N, Shetgaonkar P, Dang A, Rataboli PV: Cetirizineinduced anaphylaxis: a rare adverse drug reaction. Br J Clin Pharmacol. 2009
  17. Inomata N, Tatewaki S, Ikezawa Z: Multiple H1-antihistamineinduced urticaria. J Dermatol 2009
  18. Barbaud A, Reichert-Penetrat S, Trechot P, et al.: The use of testing in the investigation of cutaneous adverse drug reactions Br J Derma